TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
Research reports on HIV/AIDS from J. Smith and colleagues provide new insights
September 9th, 2008
According to a study from the United States, "To summarize current treatment options and guidelines for treatment of HBV infection and HIV-HBV co-infection, including a review of the relevant antiviral agents. Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infection have caused large global epidemics, which may overlap because they are transmitted by similar routes, including sex and injection drug use." "About 30% of individuals with chronic HBV infection develop cirrhosis, and 5% to 10% develop hepatocellular cancer (HCC). In HBV-HIV co-infection, HIV decreases the rate at which hepatitis B ''E'' antigen (HBeAg) is lost, increases levels of HBV DNA,...
Source: TB & Outbreaks Week (2008-09-09)
|
